Anticancer agent 235

Anticanceragent 235 (Compound 49) is a small molecule PI3K/AKT/mTOR pathway modulator that induces oxidative stress and mitochondrial dysfunction, leading to cell cycle arrest and apoptosis. It demonstrates potent in vitro anti-proliferative activity against various cancer cell lines, including HCT116 and Caco-2, supporting its use in oncology and signal transduction research.